Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Researchers have identified 15 key blood proteins that are expressed differently in Kenyan women who have exhibited resistance to HIV infection than they are among women who are susceptible to infection. About half these proteins were more common in the resistant women, while half were less common. Researchers plan to create microbicides that mimic the proteins' functions and concentrations. --------------------- Early studies of the Ardea Biosciences experimental nonnuke RDEA806 indicate the compound has a high genetic barrier to resistance and little cross-resistance with other meds in its class, according to researchers reporting at the 48th International Conference on Antimicrobial Agents and Chemotherapy. --------------------- Norvir, when used with interferon-based hepatitis C treatment, can hamper the effectiveness of hepatitis therapy, researchers reported at ICAAC. Ziagen was shown to have no adverse effect. A second study presented at the Ninth International Congress on Drug Therapy in HIV Infection has shown that both Reyataz and Intelence are safe and well tolerated among HIVers coinfected with hepatitis B or C. --------------------- Lexiva is just as effective with a lower 100-milligram booster dose of Norvir as with the currently recommended 200-milligram booster, according to a study presented at ICAAC. --------------------- TAT2, a chemical found in plants that are commonly used in Chinese herbal therapy, can prolong the life of the immune system's killer T cells, allowing them to fight HIV longer, according to a study in the November 15 edition of the Journal of Immunology. Researchers now hope to develop TAT2-based treatments to slow HIV disease progression. --------------------- Investigational HIV maturation inhibitor bevirimat was shown to significantly suppress HIV viral levels in treatment-experienced HIVers with infections resistant to at least one anti-HIV medication, according to results of a Phase II clinical study. --------------------- A comparison of Epzicom and Truvada, taken in combination with Kaletra, indicates that both medications have comparable virologic efficacy and safety among both treatment-experienced and treatment-naive HIVers through 96 weeks of therapy. --------------------- A Phase III study of Isentress has shown that the integrase inhibitor is more effective in boosting CD4-cell levels and has significantly fewer side effects than the nonnucleoside reverse transcriptase inhibitor Sustiva. Isentress's maker, Merck, has filed an application with the Food and Drug Administration for approval of the antiretroviral medication for first-line therapy; it currently is approved only for treatment-experienced HIV-positive individuals. --------------------- GeoVax Labs has announced the launch of a Phase IIa human clinical trial of its experimental 'prime-boost' HIV vaccine, which uses three key HIV proteins to first prime the body's immune system to recognize and attack an invading virus and then boost antiviral activity against it. The trial is under way at 12 sites in North America and South America.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
Diets that mimic fasting reverse aging: study
March 07 2024 5:28 PM
The Most Amazing HIV Allies & Advocates of 2023
November 03 2023 12:51 PM
PrEP without a prescription now a reality in California
February 06 2024 8:37 PM
This OnlyFans Star Is Trying to Raise $100K to Fight HIV
December 26 2023 3:05 PM
Injectable HIV treatment, prevention: Everything you need to know
March 26 2024 3:28 PM
The naked Black body takes center stage in this HIV campaign
January 03 2024 1:07 PM
8 dating tips for gay men from a gay therapist
March 21 2024 2:50 PM
Mr. Gay World wants to make sure you're OK
January 02 2024 4:56 PM
Plus: Featured Video
Latest Stories
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
Todrick Hall has long supported the communities he comes from
April 17 2024 12:02 PM
Our May/June issue of Plus is here!
April 17 2024 12:00 PM
Giselle Byrd is taking center stage — and helping others do the same
April 10 2024 2:24 PM
Discover endless fun at The Pride Store: Games & electronics for all ages
April 09 2024 4:25 PM
Mean Girls' Daniel Franzese on playing an HIV+ character
April 09 2024 3:57 PM
HIV-positive Air Force, Navy servicemembers victorious in lawsuit
April 09 2024 3:02 PM
Unlocking a new level of beauty with Dr Botanicals' ethical skincare line
April 08 2024 3:40 PM
Unleash your wild side with The Pride Store’s beginner’s guide to kink
April 08 2024 3:35 PM
Why are mpox cases in the U.S. on the rise again?
April 08 2024 1:30 PM
Happy national foreskin day!
April 04 2024 1:45 PM
Adult entertainment icons Derek Kage & Cody Silver lead fight for free speech
April 03 2024 3:06 PM
LGBTQ+ patients twice as likely to face discrimination: survey
April 02 2024 4:57 PM
Spring into The Pride Store’s top new arrivals for April
April 02 2024 4:39 PM
Nashville PD Must Pay HIV-Positive Man Denied a Job
April 01 2024 6:22 PM
Common has a message on how to foster self-love
March 29 2024 7:33 PM
Listen to Dr. Levine: Take syphilis seriously
March 28 2024 6:40 PM
Breaking boundaries in gender-free fashion with Stuzo Clothing
March 27 2024 2:15 PM
Find your perfect fit with gender-inclusive fashion from The Pride Store
March 26 2024 2:16 PM